Stada cuts loan size and tightens pricing ahead of commitment deadline

Stada, the German pharmaceutical firm, has shrunk its leveraged loan by €250m and increased its high yield bond by the same amount, ahead of the loan's commitment deadline on Thursday.

  • By Bianca Boorer
  • 21 Sep 2017

The seven year term loan was initially intended to be for €1.95bn and the bond for €875m (see corporate bond section for more on the bond).

“The bond was multiple times subscribed [due to] strong demand there,” said a banker on the deal. "[It’s] not a sign of ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 17,951.43 72 7.21%
2 BNP Paribas 15,800.30 101 6.35%
3 Goldman Sachs 14,057.92 58 5.65%
4 HSBC 13,442.80 86 5.40%
5 Deutsche Bank 12,920.94 75 5.19%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 5,988.32 51 7.65%
2 Goldman Sachs 5,851.83 48 7.48%
3 Deutsche Bank 5,236.76 54 6.69%
4 Credit Suisse 4,633.16 52 5.92%
5 Barclays 4,263.74 37 5.45%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 29,958.08 234 10.56%
2 Citi 23,883.44 190 8.42%
3 Bank of America Merrill Lynch 23,183.88 205 8.17%
4 Goldman Sachs 20,887.87 148 7.36%
5 Barclays 19,256.47 129 6.79%